Two Bevacizumab-Based Combination Regimens Equally Effective In Patients With Metastatic

-- Combining bevacizumab (BEV) with capecitabine plus irinotecan (XELIRI) is an effective alternative to BEV plus 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in patients with metastatic colorectal cancer (mCRC), researchers reported here at the 11th World Gastrointestinal Cancer Cong...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

G20 vows to spur fragile growth - BBC

Family shock at Briton's bar murder A British father on a road-trip through the - Wharfvalley

Tory hostility to EU extradition law 'risks new Costa del Crime' - Observer

Mosque worshipers knew Fort Hood suspect Hasan was troubled - Scripps Howard News Service

Most Who Want Swine Flu Shot Can't Get It - KIVI-TV

Featured Members

Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry

Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map